Human Genome Epidemiology Literature Finder
|
Records 1 - 23 (of 23 Records) |
| Query Trace: Disease Progression and RB1[original query] |
|---|
| Influence of MDM2 and MDM4 on development and survival in hereditary retinoblastoma. Pediatric blood & cancer 2012 Jul 59 (1): 39-43. de Oliveira Reis Adriana Helena, de Carvalho Ivna Néria Silva Ribamar, de Sousa Damasceno Paula Batista, Ferman Sima Esther, Lucena Evandro, Lopez-Camelo Jorge Santiago, Seuánez Héctor N, Vargas Fernando Reg |
| Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. Thyroid : official journal of the American Thyroid Association 2016 Sep . Grubbs Elizabeth G, Williams Michelle D, Scheet Paul, Vattathil Selina, Perrier Nancy, Lee Jeffrey E, Gagel Robert F, Hai Tao, Feng Lei, Cabanillas Maria, Cote Gilbert |
| Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Oct . Zilberg Catherine, Lee Matthew Weicai, Yu Bing, Ashford Bruce, Kraitsek Spiridoula, Ranson Marie, Shannon Kerwin, Cowley Mark, Iyer N Gopalakrishna, Palme Carsten E, Ch'ng Sydney, Low Tsu-Hui Hubert, O'Toole Sandra, Clark Jonathan R, Gupta Ru |
| Mutation Detection in Tumor-Derived Cell Free DNA Anticipates Progression in a Patient With Metastatic Colorectal Cancer. Frontiers in oncology 2018 8 8 306. de Figueiredo Barros Bruna D, Kupper Bruna E C, Aguiar Junior Samuel, de Mello Celso A L, Begnami Maria D, Chojniak Rubens, de Souza Sandro J, Torrezan Giovana T, Carraro Dirce |
| Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018 Mar . Vatrano Simona, Volante Marco, Duregon Eleonora, Giorcelli Jessica, Izzo Stefania, Rapa Ida, Votta Arianna, Germano Antonina, Scagliotti Giorgio, Berruti Alfredo, Terzolo Massimo, Papotti And Mau |
| EGFR mono-antibody salvage therapy for locally advanced and distant metastatic penile cancer: Clinical outcomes and genetic analysis. Urologic oncology 2019 01 37 (1): 71-77. Huang Kang-Bo, Liu Ran-Yi, Peng Qi-Hua, Li Zai-Shang, Jiang Li-Juan, Guo Sheng-Jie, Zhou Qiang-Hua, Liu Ting-Yu, Deng Chuang-Zhong, Yao Kai, Qin Zi-Ke, Liu Zhuo-Wei, Li Yong-Hong, Han Hui, Zhou Fang-Ji |
| Clinical outcomes associated with pathogenic genomic instability mutations in prostate cancer: a retrospective analysis of US pharmacy and medical claims data. Journal of medical economics 2019 7 22 (10): 1080-1087. Liu Jinan, Near Aimee, Chiarappa Joseph A, Wada Keiko, Tse Jenny, Burudpakdee Chakkarin, Behl Ajay, Ranganath Radhika, Antonarakis Emmanuel |
| Integrative molecular characterization of Chinese prostate cancer specimens. Asian journal of andrology 2019 May . Lv Shi-Dong, Wang Hong-Yi, Yu Xin-Pei, Zhai Qi-Liang, Wu Yao-Bin, Wei Qiang, Huang Wen-H |
| TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer. Clinical genitourinary cancer 2019 Nov . Chapman Lynne, Ledet Elisa M, Barata Pedro C, Cotogno Patrick, Manogue Charlotte, Moses Marcus, Christensen Bryce R, Steinwald Peter, Ranasinghe Lahiru, Layton Jodi L, Lewis Brian E, Sartor Oliv |
| ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study. Neuroendocrinology 2020 Oct . Gerard Laura, Garcia Jessica, Gauthier Arnaud, Lopez Jonathan, Durand Alice, Hervieu Valérie, Lemelin Annie, Chardon Laurence, Landel Verena, Gibert Benjamin, Lombard-Bohas Catherine, Payen Lea, Walter Thom |
| Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors. JCO precision oncology 2021 9 5 . Einstein David J, Arai Seiji, Calagua Carla, Xie Fang, Voznesensky Olga, Capaldo Brian J, Luffman Christina, Hecht Jonathan L, Balk Steven P, Sowalsky Adam G, Russo Joshua |
| Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study. BMC medicine 2021 9 19 (1): 206. Zhang Yongchang, Zhang Xiangyu, Zhang Ruiguang, Xu Qinqin, Yang Haiyan, Lizaso Analyn, Xu Chunwei, Liu Jun, Wang Wenxian, Ou Sai-Hong Ignatius, Zhang Jiexia, Song Zhengbo, Yang No |
| Use of Circulating Tumor DNA for the Clinical Management of Metastatic Castration-Resistant Prostate Cancer: A Multicenter, Real-World Study. Journal of the National Comprehensive Cancer Network : JNCCN 2021 5 19 (8): 905-914. Dong Baijun, Fan Liancheng, Yang Bin, Chen Wei, Li Yonghong, Wu Kaijie, Zhang Fengbo, Dong Haiying, Cheng Huihua, Pan Jiahua, Zhu Yinjie, Chi Chenfei, Dong Liang, Sha Jianjun, Li Lei, Yao Xudong, Xue W |
| AhRR methylation contributes to disease progression in urothelial bladder cancer. Cancer biomarkers : section A of Disease markers 2022 9 35 (2): 167-177. El-Haddad Nataly W, El Kawak Michelle, El Asmar Khalil, Jabbour Michel E, Moussa Mohamad A, Habib Rima R, Dhaini Hassan |
| Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease Progression. Cancers 2023 8 15 (15): . Sungun Bang, Dongju Won, Saeam Shin, Kang Su Cho, Jae Won Park, Jongsoo Lee, Young Deuk Choi, Suwan Kang, Seung-Tae Lee, Jong Rak Choi, Hyunho H |
| Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer. Genome medicine 2023 7 15 (1): 55. Yeon Hee Park, Seock-Ah Im, Kyunghee Park, Ji Wen, Kyung-Hun Lee, Yoon-La Choi, Won-Chul Lee, Ahrum Min, Vinicius Bonato, Seri Park, Sripad Ram, Dae-Won Lee, Ji-Yeon Kim, Su Kyeong Lee, Won-Woo Lee, Jisook Lee, Miso Kim, Hyun Seon Kim, Scott L Weinrich, Han Suk Ryu, Tae Yong Kim, Stephen Dann, Yu-Jin Kim, Diane R Fernandez, Jiwon Koh, Shuoguo Wang, Song Yi Park, Shibing Deng, Eric Powell, Rupesh Kanchi Ravi, Jadwiga Bienkowska, Paul A Rejto, Woong-Yang Park, Zhengyan K |
| Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2?+?metastatic breast cancer. Scientific reports 2023 6 13 (1): 9928. Kyoungmin Lee, Jongwon Lee, Jungmin Choi, Sung Hoon Sim, Jeong Eun Kim, Min Hwan Kim, Yeon Hee Park, Jee Hyun Kim, Su-Jin Koh, Kyong Hwa Park, Myoung Joo Kang, Mi Sun Ahn, Kyoung Eun Lee, Hee-Jun Kim, Hee Kyung Ahn, Han Jo Kim, Keon Uk Park, In Hae Pa |
| Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. European journal of cancer (Oxford, England : 1990) 2023 3 185 105-118. Lozano Rebeca, Castro Elena, Lopez-Campos Fernando, Thorne Heather, Ramirez-Backhaus Miguel, Aragon Isabel M, Cendón-Florez Ylenia, Gutierrez-Pecharroman Ana, Salles Daniela C, Romero-Laorden Nuria, Lorente David, González-Peramato Pilar, Calatrava Ana, Alonso Concepción, Anido Urbano, Arévalo-Lobera Sara, Balmaña Judith, Chirivella Isabel, Juan-Fita María José, Llort Gemma, Y Cajal Teresa Ramón, Almagro Elena, Alameda Daniel, López-Casas Pedro P, Herrera Bernardo, Mateo Joaquin, Pritchard Colin C, Antonarakis Emmanuel S, Lotan Tamara L, Rubio-Briones José, Sandhu Shahneen, Olmos Dav |
| Prognostic value of circulating tumor DNA using target next-generation sequencing in extensive-stage small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 2 178 11-19. Zhang Jiexia, Zhou Ningning, Deng Huojin, Chen Xin, Chen Qunqing, Wang Qiongyao, Sun Lei, Wen Yang, Cao Xiaolong, Luo Zhiqiang, Zhang Jian, Zhu Weiliang, Guo Linla |
| Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 10 . Paul Stockhammer, Michael Grant, Anna Wurtz, Giorgia Foggetti, F Expósito, Jianlei Gu, Hongyu Zhao, Jungmin Choi, Sangyun Chung, Fangyong Li, Zenta Walther, Julia Dietz, Emily Duffield, Scott Gettinger, Katerina Politi, Sarah B Goldbe |
| Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma. Cancers 2023 1 15 (1): . Zhou Maggie, Bui Nam, Rathore Richa, Sudhaman Sumedha, George Giby V, Malashevich Allyson K, Malhotra Meenakshi, Liu Minetta C, Aleshin Alexey, Ganjoo Kristen |
| Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 2024 4 8 e2300647. Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwa |
| Non-RB1 germline cancer predisposing variants found in retinoblastoma patients. Genetics in medicine open 2024 12 2 101836. Ana Maria Rodriguez Barreto, Michael F Walsh, Melissa A Robbins, Audrey Mauguen, Elise M Fiala, Cristina Olcese, Dianna Haggag-Lindgren, Diana Mandelker, Jasmine H Francis, Michael F Berger, Danielle Novetsky Friedman, Kenneth Offit, David H Abrams |
- Page last reviewed:Feb 1, 2024
- Content source: